Alzheimer's, Parkinson's, ALS and other serious diseases begin 10–30 years before symptoms. Trouvera helps you understand your personal risk factors early and organize the evidence-based steps — lifestyle, nutrition, pharmacology and medical coordination — that you and your clinician can use to support healthy aging, all inside one personalized digital twin.
Patent-pending technology · Trouvera™ and all product names are trademarks of Trouvera
By the time symptoms force a diagnosis, most of the damage is done. Today's testing is fragmented, costly and sold one disease at a time — with no plan for what to do next. Trouvera exists to change both halves of that problem.
Neurodegenerative disease develops for decades before the first symptom. That window is the single greatest opportunity in preventive health — if you can see it.
Single-disease tests, clinician-ordered, with no follow-through. Detection without a plan changes nothing.
Across these diseases, evidence increasingly suggests that acting earlier may help slow or delay progression. Awareness only matters if you act on it.
A 20-year head start hands you the window. Trouvera helps you put evidence-based, modifiable factors to work — coordinated and personalized, in partnership with your clinician. The benefits can compound when these steps stack.
Exercise, sleep and vascular control — the largest modifiable risk reduction.
MIND / Mediterranean patterns linked to slower cognitive decline.
Personalized and interaction-checked through the NaturaBridge engine.
Education on therapies that may slow progression when started early — to review and decide together with your physician.
Specialist guidance, orchestrated by an AI concierge.
Consented matching to next-generation therapies, years early.
Mental health is a modifiable risk factor. Synapta™ provides physiologically-aware therapeutic support, while CommitVest™ turns intentions into sensor-verified commitment contracts so the plan actually sticks.
NeuroGuard™ monitors your medications, supplements and health signals for risky changes — catching problems before they set progression back in motion.
A longitudinal, user-owned health model that ties every lever together and personalizes each one to you.
Trouvera is built on genuine invention — a portfolio of 30+ patent-pending applications across digital twins, smartphone health sensing, personalized pharmacology and AI reliability — designed to integrate with at-home blood and genetic screening. The backend platform is deployed and the consumer apps are in active beta testing today, with the screening and prevention layers rolling out next.
A longitudinal, user-owned health model that aggregates medications, conditions, wearables, labs and gamified baselines into one evolving picture of your health — and a non-diagnostic urgency score.
Web app live · iOS in betaChecks every medication, supplement and herb combination against an interaction matrix and personalized PBPK simulation — modeling metabolism by your genetics and microbiome so the wellness regimen you and your clinician choose is safe for you.
Backend API live · iOS on TestFlight100+ free, evidence-based patient and clinical guides covering serious diagnoses — produced and continuously verified by our free educational research arm.
Live at trouvera.orgSensor-verified commitment contracts that tie prevention milestones to real accountability. Pushing onset back takes years of adherence — CommitVest is the engine that keeps a healthy-feeling person on the plan long enough for the gains to compound.
Web + backend liveA safety and alerts companion that watches for risky interactions and early changes in your health signals — surfacing them before they become problems.
iOS · TestFlightA provider-facing interface delivering full interaction verdicts, CYP enzyme conflicts and patient-specific pharmacokinetic modeling — gated by clinician credentials and patient consent.
iOS · TestFlightA fingerstick blood and genetic panel, run by partner labs and interpreted by specialists — multi-disease neuro screening that comes to you.
Rolling out nextTurns a standard smartphone into an autonomous refractometer — measuring your eyeglass prescription and tracking vision as a longitudinal health signal, no extra hardware.
iOS prototypeThe psychological layer of the twin — mood, stress and cognitive tracking with physiologically-aware, consent-based therapeutic support. Depression and chronic stress are modifiable risk factors, so caring for the mind is part of healthy aging.
In buildEvery layer of the Trouvera platform is built to feed a single, unified picture of your health — and to be trustworthy enough to act on. The stack is protected by a portfolio of patent-pending applications.
A PBPK simulation engine models how each drug and supplement behaves in your body — personalized to genetics, microbiome and real-time wearable data — and screens every combination for interactions.
Every AI-generated health insight passes through ArbiterAI™, our patent-pending decorrelated multi-model verification layer, before you ever see it — different model architectures cross-check each other so shared errors are caught and corrected before they reach you.
~5–8% → <1 in 50,000*In internal benchmarks, ArbiterAI™ is engineered to drive typical AI error rates toward near-zero through multi-model verification and human oversight. *Internal testing target — not a clinical performance guarantee.
Raw physiological signals, gamified clinical-proxy assessments and active symptom interrogation turn an ordinary phone into a continuous, longitudinal health monitor that establishes your personal baseline.
Your twin is yours. Sharing with a clinician is governed by tokenized, scope-limited, time-limited consent with verifiable deletion — and any contribution to research is opt-in and de-identified.
Trouvera's consumer features operate within FDA general-wellness boundaries. The platform provides wellness and educational information and a non-diagnostic urgency indicator — it does not diagnose, treat or replace your medical team. Always make treatment decisions with a qualified healthcare professional.
Andre founded Trouvera to close the gap between knowing a disease is coming and actually doing something about it. His work pairs a deep, patent-protected technology estate — digital twins, smartphone health sensing, personalized pharmacology and verified AI — with a simple conviction: a 20-year warning should become 20 years of action.
He leads Trouvera as a deliberately lean, AI-native company, building a platform where early detection and proven prevention finally live in one place — for patients, families and the clinicians who care for them.
Connect on LinkedIn
Trouvera.org is our free educational research arm: 100+ free, evidence-based research guides that help patients and families walk into difficult medical conversations better prepared. Every guide is verified through a multi-model review process and kept current.
Visit Trouvera.org →For investors, partners and press. Detailed materials available on request.
Questions about the platform, the apps or your account.